Strengthening Global Collaboration: U.S. & Chinese Doctors Meeting on MWA

September 2024 — Over the past five months, Baird Medical has facilitated five collaborative meetings between leading doctors from China and the United States to discuss the clinical value of microwave ablation (MWA) technology in thyroid treatments. These meetings, hosted as part of Baird Medical’s Global Thyroid Microwave Ablation Technology Exchange Conference series, have created a platform for experts to share insights, present clinical data, and discuss the latest advancements in minimally invasive techniques.

Driving International Collaboration for Thyroid Treatments

The series featured presentations from esteemed clinicians, including Dr. Ying Jiang from Zhongshan Hospital, Fudan University, and Dr. Ying Huang from Shengjing Hospital of China Medical University, highlighting the role of ultrasound-guided thermal ablation in thyroid nodule management. The meetings have provided a space for academic exchange, fostering deeper collaboration between U.S. and Chinese medical professionals. Discussions have focused on refining treatment protocols, improving procedural safety, and achieving better patient outcomes through the application of advanced MWA technology.

Expanding the Scope: Uterine Fibroid Microwave Ablation

In addition to its focus on thyroid ablation, Baird Medical also hosted its first meeting on uterine fibroids in September 2024. The Global Uterine Fibroid Microwave Ablation Technology Exchange Conference (No. 1) gathered experts to discuss the potential of MWA as a non-surgical alternative for treating benign uterine tumors. This event marks an important step in expanding the clinical use of MWA technology beyond thyroid conditions, supporting its broader adoption in gynecological applications.

Looking Ahead

By continuing to facilitate these international exchanges, Baird Medical aims to advance clinical understanding and broaden the scope of MWA’s application in various therapeutic areas. The company remains committed to fostering global partnerships to drive innovation in minimally invasive treatments and support the delivery of high-quality patient care.

Disclaimer: This post is for informational purposes only and does not constitute medical advice. The opinions expressed are those of the presenting clinicians and do not necessarily represent the views of Baird Medical. Consult a qualified healthcare provider to determine the most appropriate treatment options for individual cases.